RGC Stock Price Chart
RGC Earnings
Regencell Bioscience Holdings Ltd
$27.27
-0.32%
$-0.08
At close: May 05, 16:00:00 GMT-4
$27.89
2.27%
$0.62
Post-market: May 05, 20:00:00 GMT-4
Back
Regencell Bioscience Holdings Ltd (RGC) Earnings
Key Stats
Prev.Close
$27.36
Open
$27.98
Day's Range
$26.95 - $28.3
52 week range
$0.72 - $83.6
Volume
66.1K
Avg.Volume
358.6K
Dividend yield
--
EPS (TTM)
-0.01
Market Cap
$13.7B
What is RGC?
Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company employs 12 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
